← All indications
Lymphedema
Edema due to obstruction of lymph vessels or disorders of the lymph nodes.
Subtype terms (4)
More specific conditions that are subtypes of Lymphedema in the MeSH hierarchy.
- Breast Cancer Lymphedema
3 drugs (2 approved, 1 experimental)
- Elephantiasis
- Elephantiasis, Filarial
10 drugs (7 approved, 3 experimental)
- Non-Filarial Lymphedema
Drugs by status
Approved for this indication (2)
Phase 4 trials (9)
Phase 3 trials (4)
Phase 2 trials (14)
Phase 1 trials (6)
Organizations
Organization Involved with Phase 4 Indications (2)
Organization Involved with Phase 3 Indications (8)
Organization Involved with Phase 2 Indications (16)
- Eiger BioPharmaceuticals
- Herantis Pharma Plc.
- Tactile Medical
- National Center for Complementary and Integrative Health (NCCIH)
- University of London
- Danish Cancer Society
- Indiana University
- Stanford University
- University of Southern California
- University of Toronto
- University of Copenhagen
- Royal Marsden Hospital NHS Trust
- City of Hope National Medical Center
- University of Texas at Houston
- University of Wisconsin
- University of Helsinki
Organization Involved with Phase 1 Indications (6)
Organization Involved with Other Experimental Indications (10)